KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Current Leases (2019 - 2025)

Historic Current Leases for Alnylam Pharmaceuticals (ALNY) over the last 7 years, with Q3 2025 value amounting to $44.8 million.

  • Alnylam Pharmaceuticals' Current Leases rose 619.54% to $44.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.8 million, marking a year-over-year increase of 619.54%. This contributed to the annual value of $41.9 million for FY2024, which is 90.58% up from last year.
  • Latest data reveals that Alnylam Pharmaceuticals reported Current Leases of $44.8 million as of Q3 2025, which was up 619.54% from $46.1 million recorded in Q2 2025.
  • In the past 5 years, Alnylam Pharmaceuticals' Current Leases ranged from a high of $46.1 million in Q2 2025 and a low of $38.9 million during Q1 2021
  • In the last 5 years, Alnylam Pharmaceuticals' Current Leases had a median value of $41.7 million in 2024 and averaged $42.0 million.
  • As far as peak fluctuations go, Alnylam Pharmaceuticals' Current Leases skyrocketed by 3399.79% in 2021, and later tumbled by 321.22% in 2024.
  • Quarter analysis of 5 years shows Alnylam Pharmaceuticals' Current Leases stood at $40.5 million in 2021, then rose by 3.5% to $42.0 million in 2022, then dropped by 1.09% to $41.5 million in 2023, then increased by 0.91% to $41.9 million in 2024, then grew by 6.85% to $44.8 million in 2025.
  • Its Current Leases stands at $44.8 million for Q3 2025, versus $46.1 million for Q2 2025 and $46.0 million for Q1 2025.